Introducing IndianIPR.com: The Most Affordable IP Database

/ By / Uncategorized

I chanced upon an IP Database, “IndianIPR.com” and wrote to its founder, Manpreet Singh Sood to find out more. Upon being given access, I browsed it and found it to be an excellent resource for those of us looking for easy access to tailored India IP Information. In particular, it contains: i) Reported IP judgmentsii) All acts of Parliament, rules, forms, circulars and notifications pertaining to Indian IP. Importantly, the search engine is efficient and comprehensive and throws up results […]

Introducing IndianIPR.com: The Most Affordable IP Database Read More »

WHERE DO WE GO? CHENNAI LIVE 104.8 FM ASKS THE MADRAS HIGH COURT

/ By / Uncategorized

The name of the case is: Indian Performing Rights Society Ltd. & Ors. v. Branch Manager, Muthoot Finance Private Limited, Chennai & Ors, [2009 INDLAW MAD 697].  This case was filed before the Madras High Court by the Plaintiff Copyright Society against the Respondent Radio Channel, the former seeking to restrain the Respondent and it’s agents from communicating to the public, any musical and literary works of the members of the Plaintiff’s Society in the form of a broadcast on

WHERE DO WE GO? CHENNAI LIVE 104.8 FM ASKS THE MADRAS HIGH COURT Read More »

Parallel Imports and Exhaustion: A Different Framework for Copyrights?

/ By / Copyright

Justice Ravindra Bhat of the Delhi High Court has – through several important judgments – helped advance the understanding of intellectual property law in the country. While his judgments need not necessarily be seen as the only correct point of view, they at least have helped stimulate debate on several important issues. On this blog itself, his decisions have been the subject of much discussion, as evidenced in posts linked here. His recent judgment in CS(OS) No. 1692/2006, Warner Bros.

Parallel Imports and Exhaustion: A Different Framework for Copyrights? Read More »

Do Patents Kill? A Strange Twist in the Ramkumar vs Samsung Saga

/ By / Others

Do Patents Kill? This question, often posed in the context of pharmaceuticals may have found its answer in a case involving an electronics patent.A number of papers report that a death in Chennai could be connected with the ongoing Ramkumar vs Samsung (and others) patent litigation, a litigation that we have been tracking on this blog. The last update we carried was that of a ridiculously cryptic ex parte injunction by the Madras High Court on the 13th of March.

Do Patents Kill? A Strange Twist in the Ramkumar vs Samsung Saga Read More »

Beware Mumbaikars: The Slumlord’s Act could detain you for a year for simply buying a pirated DVD

/ By / Copyright

The ToI in a detailed report a few weeks ago reported that President Patil had given her assent to an amendment to the Maharashtra Prevention of Dangerous Activities of Slumlords, Bootleggers and Drug Offenders Act (hereinafter the “Slumlord Act”). As per the ToI report this amendment to the Slumlord Act makes it a criminal offence not only to sell pirated DVDs/CDs but also to buy such pirated DVDs/CDs! As outrageous as it may seem to most of us the fact

Beware Mumbaikars: The Slumlord’s Act could detain you for a year for simply buying a pirated DVD Read More »

Please Sign Patent Petition: It Hardly Takes a Minute!

/ By / Uncategorized

We want to thank many of our readers for supporting the transparency cause and signing our petition requesting for the publishing of more “patent” information. As you will appreciate, the publishing of more patent information will make the patent prosecution process more transparent and the patent office more accountable. Thus far, we have around 100 signatures. Given that we have a regular subscription list of over 1500 members (representing patent attorneys, inhouse counsels, NGO’s, students, government folks and other members

Please Sign Patent Petition: It Hardly Takes a Minute! Read More »

The Swine Flu Outbreak: Cipla on a Patent Roll

/ By / Patent

Clearly the gods are smiling on Cipla. First, they win a patent battle over a highly profitable anti cancer drug, Tarceva. Simultaneously, a deadly swine flu strikes and claims several human lives in North America. As nations scramble to address a potential pandemic, Cipla has a generic version of Tamiflu ready to supply any government that wishes to stockpile this drug. Gilead’s Patented “Tamiflu” Tamiflu, a drug patented by Gilead and exclusively licensed for manufacture and sale to Roche is

The Swine Flu Outbreak: Cipla on a Patent Roll Read More »

Petition for More Patent Information: Please Lend Your Support and Signatures

/ By / Uncategorized

Our petition calling for greater transparency and the publication of more patent information has now been posted for signatures at i-petitions. Please click here to access this petition and sign. Please also include your name and designation–as this will lend greater impact to the campaign. Since there is no specific column for your designation and the institution that you represent, can you please include this in brackets after your name? Your support will ensure that we have greater access to

Petition for More Patent Information: Please Lend Your Support and Signatures Read More »

A Petition Pleading for Greater Transparency and More Access to Patent Information

/ By / Patent

To: Mr P.H. Kurian Controller General of Patents, Designs & Trade Marks Indian Patent Office Bhoudhik Sampada Bhavan Near Antop Hill Head Post Office, S.M. Road, Antop Hill, Mumbai-400037, Dear Mr Kurian, On behalf of several intellectual property stakeholders that are signatories to this letter, let me begin by wishing you a very happy World Intellectual Property Day. I include all members of the public in this group of stakeholders, as the public are not only interested in technological progress

A Petition Pleading for Greater Transparency and More Access to Patent Information Read More »

Roche vs Cipla: Did the Judges Construe the Claim At All?

/ By / Uncategorized

I’m still coming to grips with the division bench ruling in the Roche vs Cipla matter. I wanted to put out some initial thoughts in the hope that I can get a bit more clarity from some of our more knowledgeable readers. The facts, known to most of you are briefly as below:Roche sued Cipla before the Delhi High Court claiming that “Erlocip”, a generic product by Cipla corresponding to Roche’s originator drug, “Tarceva” violates Roche’s Indian patent (IN196774)–hereafter ‘774

Roche vs Cipla: Did the Judges Construe the Claim At All? Read More »

Scroll to Top